These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Itoh N Cell Tissue Res; 2010 Oct; 342(1):1-11. PubMed ID: 20730630 [TBL] [Abstract][Full Text] [Related]
5. Mini-review: endocrine actions of fibroblast growth factor 19. Jones S Mol Pharm; 2008; 5(1):42-8. PubMed ID: 18179175 [TBL] [Abstract][Full Text] [Related]
6. Endocrine Fibroblast Growth Factors in Relation to Stress Signaling. Shimizu M; Sato R Cells; 2022 Feb; 11(3):. PubMed ID: 35159314 [TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factors: new insights, new targets in the management of diabetes. Kyrou I; Weickert MO; Gharanei S; Randeva HS; Tan BK Minerva Endocrinol; 2017 Sep; 42(3):248-270. PubMed ID: 27412358 [TBL] [Abstract][Full Text] [Related]
8. Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis. Zangerolamo L; Carvalho M; Velloso LA; Barbosa HCL Eur J Pharmacol; 2024 Jan; 963():176248. PubMed ID: 38056616 [TBL] [Abstract][Full Text] [Related]
9. The FGF metabolic axis. Li X Front Med; 2019 Oct; 13(5):511-530. PubMed ID: 31495905 [TBL] [Abstract][Full Text] [Related]
10. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor. Goetz R; Ohnishi M; Kir S; Kurosu H; Wang L; Pastor J; Ma J; Gai W; Kuro-o M; Razzaque MS; Mohammadi M J Biol Chem; 2012 Aug; 287(34):29134-46. PubMed ID: 22733815 [TBL] [Abstract][Full Text] [Related]
11. The structural biology of the FGF19 subfamily. Beenken A; Mohammadi M Adv Exp Med Biol; 2012; 728():1-24. PubMed ID: 22396159 [TBL] [Abstract][Full Text] [Related]
12. Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women. Ramanjaneya M; Bensila M; Bettahi I; Jerobin J; Samra TA; Aye MM; Alkasem M; Siveen KS; Sathyapalan T; Skarulis M; Atkin SL; Abou-Samra AB Front Endocrinol (Lausanne); 2020; 11():568500. PubMed ID: 33101202 [No Abstract] [Full Text] [Related]
13. The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis? Ghanem M; Archer G; Crestani B; Mailleux AA Pharmacol Ther; 2024 Jul; 259():108669. PubMed ID: 38795981 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Degirolamo C; Sabbà C; Moschetta A Nat Rev Drug Discov; 2016 Jan; 15(1):51-69. PubMed ID: 26567701 [TBL] [Abstract][Full Text] [Related]
15. FGF19 subfamily members: FGF19 and FGF21. Dolegowska K; Marchelek-Mysliwiec M; Nowosiad-Magda M; Slawinski M; Dolegowska B J Physiol Biochem; 2019 Jun; 75(2):229-240. PubMed ID: 30927227 [TBL] [Abstract][Full Text] [Related]
16. Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis. Wu X; Li Y Aging (Albany NY); 2009 Dec; 1(12):1023-7. PubMed ID: 20157585 [TBL] [Abstract][Full Text] [Related]
17. The Role of Fibroblast Growth Factor 19 Subfamily in Different Populations Suffering From Osteoporosis. Yu X; Xia Y; Jia J; Yuan G Front Endocrinol (Lausanne); 2022; 13():830022. PubMed ID: 35574015 [TBL] [Abstract][Full Text] [Related]
18. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling. Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135 [TBL] [Abstract][Full Text] [Related]
19. Circadian Regulation of Endocrine Fibroblast Growth Factors on Systemic Energy Metabolism. Yang Z; Zarbl H; Guo GL Mol Pharmacol; 2024 Feb; 105(3):179-193. PubMed ID: 38238100 [TBL] [Abstract][Full Text] [Related]
20. Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy. Itoh N; Ohta H; Konishi M Front Endocrinol (Lausanne); 2015; 6():154. PubMed ID: 26483756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]